Form 4 for ELAN Elanco Animal Health Inc
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-05 · accession 0001415889-23-004468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-07 | 2023-03-05 | ELAN | Simmons Jeffrey N | Pres, CEO AND Dir, Dir | F - Tax | $11.10 | -10.7K | 1.14M | -0.9% | -$118.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-05 | F | D | 10,696 | $11.10 | 1,142,569 | D | — | — | (F1) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan. |